Banyan Biomarkers banyanbio.com


Banyan Biomarkers has created a Point of Care (POC) Blood Test to diagnose traumatic brain injury (TBI). Currently no blood test exists for use by physicians to detect the presence and severity of brain trauma. Banyan Biomarkers' research has identified unique biomarkers present in the patient's blood following injury to the brain. The detection and quantification of these biomarkers may provide early indications of brain trauma essential for earlier intervention and management.

Banyan Biomarkers has created a Point of Care (POC) Blood Test to diagnose traumatic brain injury (TBI). Currently no blood test exists for use by physicians to detect the presence and severity of brain trauma. Banyan Biomarkers' research has identif...Show all

Company (Alive / Active)

Phone: 760-710-0460

Fax:

16744 West Bernardo Drive

San Diego, 92127
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Banyan Biomarkers $20.9M Jan 1, 2017
See all 36 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Banyan Biomarkers Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

PharMetrics

Watertown, Massachusetts, United States
AcquiredPharMetrics is a provider of an integrated database of patient-level data including outcomes and pharmaceutical claims informationLogin to see details

Stemina Biomarker Discovery

Madison, Wisconsin, United States
Alive / ActiveStemina Cell Discovery discovers and validates small molecules as biomarkers for high-throughput drug screening and disease diagnostics using an all human system comprised of stem cells and the company's metabolomics platform. Metabolomics aims to enable the discovery of small molecules that can be used as candidate biomarkers of disease and pharmacological efficacy or toxicity. The human embryonic stem cell metabolome is a source of candidate biomarkers to predict, diagnose or measure the progr...Show allLogin to see details
See all 36 competitors